International Journal of Health Policy and Management

Understanding Heterogeneous Drug Procurement Behaviour of Healthcare Institutions Under Pooled Procurement: Evidence From China

Articles in Press, Corrected Proof, Available Online from 07 June 2026

Boya Zhao, Zhao Cheng, Xing Lin Feng

• View Article
• PDF 1 M

Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance

Volume 12, Issue 1, 2023, Pages 1-2

10.34172/ijhpm.2023.7972

jinmiao Lu, Xiaohua Ying, Zhiping Li

• View Article
• PDF 478.12 K

Validation of Instruments for Assessing Drug Safety Management During the Conduction of Clinical Trials

Volume 7, Issue 7, 2018, Pages 623-629

10.15171/ijhpm.2017.140

Yaimarelis Saumell, Olga Torres, Maritza Batista, Lizet Sánchez

• View Article
• PDF 576.89 K

Considering the Future of Pharmaceutical Promotions in Social Media; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”

Volume 5, Issue 4, 2016, Pages 283-285

10.15171/ijhpm.2016.15

Francesca Renee Dillman Carpentier

• View Article
• PDF 343.03 K